Skip to content
mystocks Logo
Colossal

Colossal

Coming Soon
Biotechnology
Secondary Allocation

Implied Valuation

$8.00B

Price per Share

$11.25

AI Investment Thesis

VALUATION TRAJECTORY
Registry audit of capital round evolution.
Program Mandate

Colossal Biosciences is a de-extinction company that aims to resurrect extinct species, starting with the woolly mammoth. By leveraging CRISPR gene-editing technology, they hope to restore ecosystems and combat climate change. This round is to fund the development of artificial wombs and further genetic engineering research.

Deployment Terms
Vehicle StructureAugment Collective SPV
Carried Interest0%
Platform Setup Fee1.9%
Management Fee0% p.a.
Ownership TypeIndirect
Funding History
RoundDateAmountValuation
Series B
Jan 2023$150.0M$1.0B
Series A
Mar 2022$60.0M$0.3B
Seed
Sep 2021$15.0M$0.1B
Current Offering
Live Now-$11.25 / Share

Private market risk — capital at risk

Private market and pre-IPO investments are high-risk and illiquid. You may lose your entire investment, there is no public market in which to sell your holding, and any return may take years to materialise — a future listing is never guaranteed. This page is general information, not financial advice or an offer to sell securities. Read our risk disclosure before investing.